Adoptive t-cell therapy for cancer in the United Kingdom: a review of activity for the British Society of Gene and Cell Therapy Annual Meeting 2015

Gilham, David Edward, Anderson, John, Bridgeman, John Stephen, Hawkins, Robert Edward, Exley, Mark Adrian, Stauss, Hans, Maher, John, Pule, Martin, Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135, Bendle, Gavin, Lee, Steven, Qasim, Waseem, Thrasher, Adrian and Morris, Emma 2015. Adoptive t-cell therapy for cancer in the United Kingdom: a review of activity for the British Society of Gene and Cell Therapy Annual Meeting 2015. Human Gene Therapy 26 (5) , pp. 276-285. 10.1089/hum.2015.024

Full text not available from this repository.

Abstract

Adoptive T-cell therapy is delivering objective clinical responses across a number of cancer indications in the early phase clinical setting. Much of this clinical activity is taking place at major clinical academic centers across the United States. This review focuses upon cancer-focused cell therapy activity within the United Kingdom as a contribution to the 2015 British Society of Gene and Cell Therapy annual general meeting. This overview reflects the diversity and expansion of clinical and preclinical studies within the United Kingdom while considering the background context of this work against new infrastructural developments and the requirements of nationalized healthcare delivery within the UK National Health Service.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	Q Science > QR Microbiology > QR180 Immunology R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Publisher:	Mary Ann Liebert
ISSN:	1043-0342
Date of Acceptance:	31 March 2015
Last Modified:	28 Oct 2022 10:38
URI:	https://orca.cardiff.ac.uk/id/eprint/79071

Citation Data

Cited 14 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item